The proposed upcoming breast cancer prevention trial is designed as a double blind, randomized study in which 22, 000 postmenopausal women age 35 years or older will be assigned to take either tamoxifen 20 mg orally or raloxifene 60 mg orally for 5 years buy cialis online cheap